Pathophysiological Mechanisms of Fibromuscular Dysplasia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromuscular Dysplasia
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients
Time Frame: Once within 15 days
Secondary Outcomes
- Comparison of circulating micro RNAs (miR-143 ; miR-145) between the 3 arms(Once within 15 days)
- Comparison of c-reactive protein between the 3 arms(Once within 15 days)
- Comparison of pulse wave velocity between the 3 arms(Once within 15 days)
- Comparison of endothelium dependant vasodilation between the 3 arms(Once within 15 days)
- Comparison of endothelium independent vasodilation between the 3 arms(Once within 15 days)
- Comparison of matrixmetalloproteases between the 3 arms(Once within 15 days)
- Comparison of PLA2 between the 3 arms(Once within 15 days)